HistoSonics exit
Hatteras Raises $200M for Two New Funds Following HistoSonics Exit Success
Hatteras Venture Partners; $200M; venture capital; life sciences; early-stage startups; biotech; medtech; HistoSonics exit; fundraising; Hatteras Venture Fund VII; Hatteras Opportunity Fund I